Jean-Pierre Garnier

Dr Garnier is Chief Executive Officer of GlaxoSmithKline. He assumed this role in December 2000 with the merger of SmithKline Beecham and Glaxo Wellcome.

Dr Garnier joined SmithKline Beecham in 1990 as President of its pharmaceutical business in North America and served as Chairman, Pharmaceuticals from 1994 until his appointment as Chief Operating Officer in 1995. He was elected to the company's Board of Directors in 1992. He became Chief Executive Officer-elect in December 1999. He became Chief Executive Officer in April 2000.

Prior to SmithKline Beecham, Dr Garnier served as President of Schering-Plough's US business. During his 15 years at Schering, he held various management positions, including general manager of several overseas subsidiaries. In 1983, he joined the US Pharmaceutical Products Division serving as Vice President of Marketing. He was then named Senior Vice President and General Manager of the OTC business and assumed responsibility for sales and marketing for the US prescription business prior to becoming President.

Dr Garnier serves on the Boards of Directors of the United Technologies Corporation and the Eisenhower Exchange Fellowships, Inc. In January 1997, Dr Garnier was selected by President Chirac of France to receive the Chevalier de la Légion d'Honneur. Founded in 1802 by France's Emperor Napoleon I, the Légion honours individuals for their civilian or military accomplishments. In April 1997, he received from the Cancer Research Institute the Oliver R Grace Award for Distinguished Service in Advancing Cancer Research. In 2001, he was named one of 50 "Stars of Europe" by BusinessWeek magazine and presented with the Marco Polo Award for GlaxoSmithKline's commitment to China. In 2002, he received the Humanitarian Award from the Sabin Vaccine Institute, and the Legend Lifetime Achievement Award from the Eastern Technology Council.

Dr Garnier holds a PhD in pharmacology and an MS in pharmaceutical science from the University of Louis Pasteur in France. As a Fulbright Scholar, he earned an MBA at Stanford University, California, in 1974. In March 2002, he was honoured with the Fulbright Association's Lifetime Achievement Medal.